Stockscreener 앱 받기
3.0043
10.56%
0.2843
Editas Medicine Inc 주식(EDIT)의 최신 뉴스
Editas Medicine’s SWOT analysis: gene editing stock’s potential amid challenges - Investing.com
Gene Editing Market Exclusive Report with Detailed Study & - openPR.com
Market Review: Is Editas Medicine Inc. a momentum stockQuarterly Profit Summary & Weekly Watchlist for Consistent Profits - خودرو بانک
Published on: 2025-09-17 01:45:33 - خودرو بانک
Why Editas Medicine Stock Was Skyrocketing This Week - MSN
Resistance Check: Can Editas Medicine Inc ride the EV waveMarket Sentiment Summary & Stock Timing and Entry Methods - خودرو بانک
Analyst Upgrade: Will Seacoast Banking Corporation of Florida outperform tech stocksQuarterly Trade Report & Low Drawdown Trading Strategies - خودرو بانک
Editas Medicine, Inc. $EDIT Shares Purchased by Ieq Capital LLC - MarketBeat
Nuveen LLC Makes New Investment in Editas Medicine, Inc. $EDIT - MarketBeat
Why Is Editas (EDIT) Down 16.9% Since Last Earnings Report? - sharewise.com
Editas Medicine Q3 EPS Estimate Increased by Zacks Research - MarketBeat
Editas Medicine, Inc.'s (NASDAQ:EDIT) Price Is Right But Growth Is Lacking After Shares Rocket 26% - 富途牛牛
Editas Medicine, Inc. (NASDAQ:EDIT) Stock Catapults 26% Though Its Price And Business Still Lag The Industry - simplywall.st
Wells Fargo & Company Issues Positive Forecast for Editas Medicine (NASDAQ:EDIT) Stock Price - MarketBeat
Editas Medicine price target raised to $4 from $3 at Wells Fargo - MSN
Is Editas Medicine Inc. a good stock for dollar cost averagingJuly 2025 Momentum & AI Driven Stock Price Forecasts - 뉴스영
Editas Medicine Bets On Next-Gen Gene Editing - Finimize
Statistical indicators supporting Editas Medicine Inc.’s strengthRate Hike & AI Driven Stock Reports - Newser
Using portfolio simulators with Editas Medicine Inc. includedJuly 2025 Sector Moves & Growth Focused Entry Reports - Newser
Analysts Have Conflicting Sentiments on These Healthcare Companies: Novan (NOVN) and Editas Medicine (EDIT) - The Globe and Mail
What drives Editas Medicine Inc.’s stock price2025 Top Gainers & Capital Efficient Trading Techniques - خودرو بانک
Bond Watch: What are Editas Medicine Inc.’s technical support levelsWeekly Profit Analysis & Consistent Return Strategy Ideas - خودرو بانک
Can Editas Medicine Inc. weather a recession2025 Year in Review & Verified Technical Signals - خودرو بانک
Can Editas Medicine Inc. expand into new markets2025 Risk Factors & Technical Buy Zone Confirmation - خودرو بانک
Predicting Editas Medicine Inc. trend using moving averages2025 Breakouts & Breakdowns & Low Risk Investment Opportunities - Newser
Volatility Watch: Is Editas Medicine Inc. stock influenced by commodity prices2025 Technical Patterns & Detailed Earnings Play Strategies - خودرو بانک
Is Editas Medicine Inc. forming a bottoming baseQuarterly Profit Summary & Safe Capital Growth Stock Tips - Newser
Editas Medicine: HC Wainwright Raises PT to $5 from $4 on Buy Rating - AInvest
Using Ichimoku Cloud for Editas Medicine Inc. technicalsWeekly Investment Report & Free Low Drawdown Momentum Trade Ideas - Newser
H.C. Wainwright Maintains Editas Medicine(EDIT.US) With Buy Rating, Maintains Target Price $5 - 富途牛牛
Is Editas Medicine Inc. stock ready for a breakoutJuly 2025 Big Picture & Smart Investment Allocation Tips - Newser
Real time scanner hits for Editas Medicine Inc. explainedMarket Weekly Review & Low Drawdown Trading Techniques - Newser
Editas Medicine at Cantor Global: CRISPR Shift and Financial Resilience By Investing.com - Investing.com Canada
Editas Medicine (NASDAQ:EDIT) Stock Price Crosses Below Fifty Day Moving AverageTime to Sell? - MarketBeat
How to escape a deep drawdown in Editas Medicine Inc.2025 Stock Rankings & Free Verified High Yield Trade Plans - Newser
Editas Medicine, Inc. (NASDAQ:EDIT) Receives $5.10 Consensus Target Price from Analysts - MarketBeat
Editas Medicine at Cantor Global: CRISPR Shift and Financial Resilience - Investing.com
Can volume confirm reversal in Editas Medicine Inc.Quarterly Earnings Report & Free Fast Gain Swing Trade Alerts - Newser
Using data models to predict Editas Medicine Inc. stock movementPortfolio Return Report & Low Risk High Reward Trade Ideas - Newser
Is Editas Medicine Inc. stock entering bullish territoryPortfolio Risk Report & Reliable Price Action Trade Plans - Newser
How to build a custom watchlist for Editas Medicine Inc.Recession Risk & AI Forecast Swing Trade Picks - Newser
Is Editas Medicine Inc. showing signs of accumulation2025 Year in Review & Low Risk High Reward Trade Ideas - Newser
Editas Nominates EDIT-401 as Lead In Vivo Therapy for High Cholesterol - Zacks Investment Research
Evaluating Editas Medicine Inc. with trendline analysisQuarterly Profit Summary & Consistent Growth Stock Picks - Newser
A Quick Look at Today's Ratings for Editas Medicine(EDIT.US), With a Forecast Between $4 to $4 - 富途牛牛
Editas Medicine at Wells Fargo Conference: Gene Editing Milestone - Investing.com
Activity Recap: How does Editas Medicine Inc. score in quality rankingsDay Trade & Free Accurate Trade Setup Notifications - خودرو بانک
0.21%
0.59%
자본화:
|
볼륨(24시간):